-
-
-
-
-
-
-
Actuate Therapeutics (ACTU) Receives FDA Orphan Drug Designation for Elraglusib for Treatment of Soft Tissue Sarcomas
-
-
-
-
-
-
-
Form S-1/A ACTUATE THERAPEUTICS,
-
68,863 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


